{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T08:31:29Z","timestamp":1781857889180,"version":"3.54.5"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-024-03741-3","type":"journal-article","created":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T14:37:34Z","timestamp":1736174254000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Combinational treatment approaches for acanthosis nigricans: a review"],"prefix":"10.1007","volume":"317","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6491-1071","authenticated-orcid":false,"given":"Aishwarya","family":"Gangwar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vipin","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,6]]},"reference":[{"key":"3741_CR1","doi-asserted-by":"publisher","unstructured":"Schwartz RA (Jul. 1994) Acanthosis nigricans. J Am Acad Dermatol 31(1):1\u201319. https:\/\/doi.org\/10.1016\/S0190-9622(94)70128-8","DOI":"10.1016\/S0190-9622(94)70128-8"},{"issue":"3","key":"3741_CR2","doi-asserted-by":"publisher","first-page":"239","DOI":"10.4103\/2229-5178.137765","volume":"5","author":"M Phiske","year":"2014","unstructured":"Phiske M (2014) An approach to acanthosis nigricans. Indian Dermatol Online J 5(3):239. https:\/\/doi.org\/10.4103\/2229-5178.137765","journal-title":"Indian Dermatol Online J"},{"key":"3741_CR3","doi-asserted-by":"publisher","unstructured":"Judge MR, McLean WHI, Munro CS (2010) Disorders of Keratinization. in Rook\u2019s Textbook of Dermatology. Wiley, pp 1\u2013122. https:\/\/doi.org\/10.1002\/9781444317633.ch19","DOI":"10.1002\/9781444317633.ch19"},{"issue":"5","key":"3741_CR4","doi-asserted-by":"publisher","first-page":"40","DOI":"10.4103\/2229-5178.144529","volume":"5","author":"A Das","year":"2014","unstructured":"Das A et al (2014) Unilateral nevoid acanthosis nigricans: uncommon variant of a common disease. Indian Dermatol Online J 5(5):40. https:\/\/doi.org\/10.4103\/2229-5178.144529","journal-title":"Indian Dermatol Online J"},{"issue":"6","key":"3741_CR5","doi-asserted-by":"publisher","first-page":"140","DOI":"10.4103\/2229-5178.146201","volume":"5","author":"V Anand","year":"2014","unstructured":"Anand V, Das A, Kumar P, Kumar R, Hassan S (2014) Acral acanthosis nigricans (acral acanthotic anomaly). Indian Dermatol Online J 5(6):140. https:\/\/doi.org\/10.4103\/2229-5178.146201","journal-title":"Indian Dermatol Online J"},{"key":"3741_CR6","doi-asserted-by":"publisher","unstructured":"Wu Q ( Dec. 2019) Andrews\u2019 diseases of the skin: Clinical dermatology, 13th edition, J Am Acad Dermatol, 81(6):e187, https:\/\/doi.org\/10.1016\/j.jaad.2019.08.041","DOI":"10.1016\/j.jaad.2019.08.041"},{"key":"3741_CR7","doi-asserted-by":"publisher","unstructured":"Chu H-W, Li J-M, Chen G-F, Ma J-Y ( Dec. 2014) Oral malignant acanthosis nigricans associated with endometrial adenocarcinoma, Int J Oral Sci, 6(4):247\u2013249,https:\/\/doi.org\/10.1038\/ijos.2014.1","DOI":"10.1038\/ijos.2014.1"},{"key":"3741_CR8","doi-asserted-by":"publisher","unstructured":"Karada\u011f AS, You Y, Danarti R, Al-Khuzaei S, Chen W (Jan. 2018) Acanthosis nigricans and the metabolic syndrome. Clin Dermatol 36(1):48\u201353. https:\/\/doi.org\/10.1016\/j.clindermatol.2017.09.008","DOI":"10.1016\/j.clindermatol.2017.09.008"},{"key":"3741_CR9","doi-asserted-by":"publisher","unstructured":"Hermanns-L\u00ea T, Hermanns JF, Pi\u00e9rard GE (Jan. 2002) Juvenile acanthosis nigricans and insulin resistance. Pediatr Dermatol 19(1):12\u201314. https:\/\/doi.org\/10.1046\/j.1525-1470.2002.00013.x","DOI":"10.1046\/j.1525-1470.2002.00013.x"},{"issue":"7","key":"3741_CR10","doi-asserted-by":"publisher","first-page":"497","DOI":"10.2165\/00128071-200203070-00006","volume":"3","author":"Garca L Hidalgo","year":"2002","unstructured":"Garca L, Hidalgo (2002) Dermatological complications of obesity. Am J Clin Dermatol 3(7):497\u2013506. https:\/\/doi.org\/10.2165\/00128071-200203070-00006","journal-title":"Am J Clin Dermatol"},{"key":"3741_CR11","doi-asserted-by":"publisher","unstructured":"Garc\u00eda-Hidalgo L, Orozco\u2010Topete R, Gonzalez\u2010Barranco J, Villa AR, Dalman JJ, Ortiz\u2010Pedroza G (May. 1999) Dermatoses in 156 obese adults. Obes Res 7(3):299\u2013302. https:\/\/doi.org\/10.1002\/j.1550-8528.1999.tb00410.x","DOI":"10.1002\/j.1550-8528.1999.tb00410.x"},{"key":"3741_CR12","doi-asserted-by":"publisher","unstructured":"Brockow K, Steinkraus V, Rinninger F, Abeck D, Ring J (Dec. 1995) Acanthosis Nigricans: A Marker for Hyperinsulinemia, Pediatr Dermatol, 12(4):323\u2013326, https:\/\/doi.org\/10.1111\/j.1525-1470.1995.tb00193.x","DOI":"10.1111\/j.1525-1470.1995.tb00193.x"},{"issue":"2","key":"3741_CR13","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1159\/000018096","volume":"198","author":"R Kuroki","year":"1999","unstructured":"Kuroki R et al (1999) Acanthosis nigricans with severe obesity, Insulin Resistance and hypothyroidism: improvement by Diet Control. Dermatology 198(2):164\u2013166. https:\/\/doi.org\/10.1159\/000018096","journal-title":"Dermatology"},{"key":"3741_CR14","doi-asserted-by":"publisher","unstructured":"Torley D, Bellus GA, Munro CS (Dec. 2002) Genes, growth factors and acanthosis nigricans. Br J Dermatol 147(6):1096\u20131101. https:\/\/doi.org\/10.1046\/j.1365-2133.2002.05150.x","DOI":"10.1046\/j.1365-2133.2002.05150.x"},{"key":"3741_CR15","doi-asserted-by":"publisher","unstructured":"Muguet Guenot L et al ( Mar. 2019), Acanthosis nigricans, hypochondroplasia, and <\u2009scp\u2009>\u2009FGFR\u20093 mutations: Findings with five new patients, and a review of the literature, Pediatr Dermatol, 36(2):242\u2013246. https:\/\/doi.org\/10.1111\/pde.13748","DOI":"10.1111\/pde.13748"},{"key":"3741_CR16","doi-asserted-by":"publisher","unstructured":"Fu J, Zhao Y, Wang T, Zhang Q, Xiao X (Dec. 2019) Acanthosis nigricans in a Chinese girl with FGFR3 K650 T mutation: a case report and literature review. BMC Med Genet 20(1):8. https:\/\/doi.org\/10.1186\/s12881-019-0748-4","DOI":"10.1186\/s12881-019-0748-4"},{"key":"3741_CR17","unstructured":"Jeong K-H, Oh S-J, Chon S, Lee M-H (2010) Generalized acanthosis nigricans related to type B insulin resistance syndrome. A Case Report CUTIS Do Not Copy"},{"key":"3741_CR18","doi-asserted-by":"publisher","unstructured":"Esperanza LE, Fenske NA (May 1996) Hyperandrogenism, insulin resistance, and acanthosis nigricans (HAIR-AN) syndrome: spontaneous remission in a 15-year-old girl. J Am Acad Dermatol 34(5):892\u2013897. https:\/\/doi.org\/10.1016\/S0190-9622(96)90074-2","DOI":"10.1016\/S0190-9622(96)90074-2"},{"key":"3741_CR19","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.30351","author":"A Purwar","year":"2022","unstructured":"Purwar A, Nagpure S (Oct. 2022) Insulin Resistance in polycystic ovarian syndrome. Cureus https:\/\/doi.org\/10.7759\/cureus.30351","journal-title":"Cureus Oct"},{"key":"3741_CR20","doi-asserted-by":"publisher","unstructured":"Higgins SP, Freemark M, Prose NS (Sep. 2008) Acanthosis nigricans: a practical approach to evaluation and management. Dermatol Online J 14(9). https:\/\/doi.org\/10.5070\/D37MF6G290","DOI":"10.5070\/D37MF6G290"},{"key":"3741_CR21","doi-asserted-by":"publisher","unstructured":"Romo A, Benavides S (Jul. 2008) Treatment Options in Insulin Resistance Obesity\u2013Related Acanthosis Nigricans, Annals of Pharmacotherapy, 42(7\u20138):1090\u20131094, https:\/\/doi.org\/10.1345\/aph.1K446","DOI":"10.1345\/aph.1K446"},{"issue":"3","key":"3741_CR22","doi-asserted-by":"publisher","first-page":"199","DOI":"10.2165\/00128071-200405030-00008","volume":"5","author":"T Hermanns-L","year":"2004","unstructured":"Hermanns-L T, Scheen A, Pirard GE (2004) Acanthosis nigricans Associated with insulin resistance. Am J Clin Dermatol 5(3):199\u2013203. https:\/\/doi.org\/10.2165\/00128071-200405030-00008","journal-title":"Am J Clin Dermatol"},{"key":"3741_CR23","doi-asserted-by":"publisher","unstructured":"Rathee P, Kumar S, Kumar D, Kumari B, Yadav SS (Jul. 2021) Skin hyperpigmentation and its treatment with herbs: an alternative method. Futur J Pharm Sci 7(1):132. https:\/\/doi.org\/10.1186\/s43094-021-00284-6","DOI":"10.1186\/s43094-021-00284-6"},{"key":"3741_CR24","doi-asserted-by":"publisher","unstructured":"Rosenbach A, Ram R (Aug. 2004) Treatment of Acanthosis Nigricans of the Axillae Using a Long-Pulsed (5-msec) Alexandrite Laser, Dermatologic Surgery,30(8):1158\u20131160, https:\/\/doi.org\/10.1111\/j.1524-4725.2004.30346.x","DOI":"10.1111\/j.1524-4725.2004.30346.x"},{"key":"3741_CR25","doi-asserted-by":"publisher","unstructured":"Ghosh S, Roychowdhury B, Mukhopadhyay S, Chowdhury S (Jul. 2008) Clearance of acanthosis nigricans associated with insulinoma following surgical resection, QJM,101(11):899\u2013900, https:\/\/doi.org\/10.1093\/qjmed\/hcn098","DOI":"10.1093\/qjmed\/hcn098"},{"key":"3741_CR26","doi-asserted-by":"publisher","unstructured":"Furr HC, McGrane MM (2003) RETINOL| physiology. in Encyclopedia of Food Sciences and Nutrition. Elsevier, pp 4957\u20134967. https:\/\/doi.org\/10.1016\/B0-12-227055-X\/01019-1","DOI":"10.1016\/B0-12-227055-X\/01019-1"},{"key":"3741_CR27","doi-asserted-by":"publisher","unstructured":"Mukherjee S, Date A, Patravale V, Korting HC, Roeder A, Weindl G (Dec. 2006) Retinoids in the treatment of skin aging: an overview of clinical efficacy and safety, Clin Interv Aging, 1(4):327\u2013348, https:\/\/doi.org\/10.2147\/ciia.2006.1.4.327","DOI":"10.2147\/ciia.2006.1.4.327"},{"key":"3741_CR28","doi-asserted-by":"publisher","unstructured":"Borthwick AD, Goncalves MB, Corcoran JPT (Oct. 2020) Recent advances in the design of RAR \u03b1 and RAR \u03b2 agonists as orally bioavailable drugs. A review, Bioorg Med Chem, 28(20):115664, https:\/\/doi.org\/10.1016\/j.bmc.2020.115664","DOI":"10.1016\/j.bmc.2020.115664"},{"key":"3741_CR29","doi-asserted-by":"publisher","unstructured":"Chen S et al (May 1995) Retinoic acid receptor Gamma mediates topical retinoid efficacy and irritation in animal models. J Invest Dermatology 104(5):779\u2013783. https:\/\/doi.org\/10.1111\/1523-1747.EP12606988","DOI":"10.1111\/1523-1747.EP12606988"},{"key":"3741_CR30","doi-asserted-by":"publisher","unstructured":"Glass CK, Rosenfeld MG (Jan. 2000) The coregulator exchange in transcriptional functions of nuclear receptors, Genes Dev, 14(2):121\u2013141, https:\/\/doi.org\/10.1101\/gad.14.2.121","DOI":"10.1101\/gad.14.2.121"},{"key":"3741_CR31","doi-asserted-by":"publisher","unstructured":"Tsuji M, Shudo K, Kagechika H (Mar. 2017) Identifying the receptor subtype selectivity of retinoid X and retinoic acid receptors via quantum mechanics, FEBS Open Bio, 7(3):391\u2013396, https:\/\/doi.org\/10.1002\/2211-5463.12188","DOI":"10.1002\/2211-5463.12188"},{"key":"3741_CR32","unstructured":"Steven H, Blobstein (2024) 34 CUTIS \u00ae Acanthosis Nigricans. Accessed: Aug. 06, [Online]. Available: https:\/\/pubmed.ncbi.nlm.nih.gov\/12553628\/#full-view-affiliation-1"},{"key":"3741_CR33","doi-asserted-by":"publisher","unstructured":"Patel NU, Roach C, Alinia H, Huang W, Feldman S (Aug. 2018) Current treatment options for acanthosis nigricans. Clin Cosmet Investig Dermatol 11:407\u2013413. https:\/\/doi.org\/10.2147\/CCID.S137527","DOI":"10.2147\/CCID.S137527"},{"key":"3741_CR34","doi-asserted-by":"publisher","unstructured":"Lee WG, Koh YG, Shin SH, Park KY, Lee HW (2023) Case series of acanthosis nigricans treated with topical trifarotene cream, J Cosmet Dermatol, 22(10):2862\u20132864, Oct. https:\/\/doi.org\/10.1111\/jocd.15777","DOI":"10.1111\/jocd.15777"},{"key":"3741_CR35","doi-asserted-by":"publisher","unstructured":"Santhosh P, Kidangazhiathmana A (Jul. 2021) Trifarotene\u2013 the latest retinoid. Indian J Dermatol Venereol Leprol 87:742. https:\/\/doi.org\/10.25259\/IJDVL_741_20","DOI":"10.25259\/IJDVL_741_20"},{"key":"3741_CR36","doi-asserted-by":"publisher","unstructured":"Aubert J et al (2018) Jul., Nonclinical and human pharmacology of the potent and selective topical retinoic acid receptor-\u03b3 agonist trifarotene, British Journal of Dermatology, https:\/\/doi.org\/10.1111\/bjd.16719","DOI":"10.1111\/bjd.16719"},{"key":"3741_CR37","unstructured":"Lahiri K, Malakar S (1996) Topical tretinoin in acanthosis nigricans Subrata Malakar Rita Skin Foundation, Indian J Dermatol Venereol Leprol.,62(3):159\u2013161, Accessed: Nov. 18, 2024.. Available: https:\/\/pubmed.ncbi.nlm.nih.gov\/20948022\/"},{"key":"3741_CR38","doi-asserted-by":"publisher","unstructured":"Darmstadt GL (Aug. 1991) Treatment of Acanthosis nigricans with Tretinoin. Arch Dermatol 127(8):1139. https:\/\/doi.org\/10.1001\/archderm.1991.01680070039003","DOI":"10.1001\/archderm.1991.01680070039003"},{"key":"3741_CR39","doi-asserted-by":"publisher","unstructured":"Berger BJ (Jul. 1973) Another use for Tretinoin\u2014Pseudoacanthosis nigricans. Arch Dermatol 108(1):133. https:\/\/doi.org\/10.1001\/archderm.1973.01620220087029","DOI":"10.1001\/archderm.1973.01620220087029"},{"key":"3741_CR40","doi-asserted-by":"publisher","unstructured":"Ahmad Nasrollahi S et al (2019) \u2009Evaluation of the safety and efficacy of a triple combination cream (hydroquinone, tretinoin, and fluocinolone) for treatment of melasma in Middle Eastern skin, Clin Cosmet Investig Dermatol, 12:437\u2013444, https:\/\/doi.org\/10.2147\/CCID.S202285.","DOI":"10.2147\/CCID.S202285"},{"issue":"1","key":"3741_CR41","doi-asserted-by":"publisher","first-page":"103","DOI":"10.4103\/0019-5154.147838","volume":"60","author":"A Treesirichod","year":"2015","unstructured":"A. Treesirichod, S. Chaithirayanon, N. Wongjitrat, P. Wattanapan The efficacy of topical 0.1% adapalene gel for use in the treatment of childhood acanthosis nigricans: a pilot study. Indian J Dermatol, 60(1):1032015 https:\/\/doi.org\/10.4103\/0019-5154.147838.","journal-title":"Indian J Dermatol"},{"key":"3741_CR42","doi-asserted-by":"publisher","unstructured":"A. Treesirichod, S. Chaithirayanon, N. Wongjitrat (May. 2019) Comparison of the efficacy and safety of 0.1% adapalene gel and 0.025% tretinoin cream in the treatment of childhood acanthosis nigricans. Pediatr Dermatol, 36(3):330\u2013334 https:\/\/doi.org\/10.1111\/pde.13799.","DOI":"10.1111\/pde.13799"},{"key":"3741_CR43","unstructured":"Steven H, Blobstein (2003) Topical therapy with tretinoin and ammonium lactate for acanthosis nigricans associated with obesity."},{"key":"3741_CR44","doi-asserted-by":"publisher","unstructured":"E. Weisshaar, B. Bonnekoh, I. Franke, H. Gollnick (May, 2001) Successful symptomatic tazarotene treatment of juvenile acanthosis nigricans of the familial obesity-associated type in insulin resistance.Der Hautarzt, 52(6):499\u2013503 https:\/\/doi.org\/10.1007\/s001050000083.","DOI":"10.1007\/s001050000083"},{"key":"3741_CR45","doi-asserted-by":"publisher","unstructured":"S. Noble, A. J. Wagstaff (Jun. 1995) Tretinoin.Drugs Aging, 6(6):479\u2013496 https:\/\/doi.org\/10.2165\/00002512-199506060-00008.","DOI":"10.2165\/00002512-199506060-00008"},{"key":"3741_CR46","doi-asserted-by":"publisher","unstructured":"M. Pan, G. Heinecke, S. Bernardo, C. Tsui, J. Levitt (2013) Urea: a comprehensive review of the clinical literature.Dermatol Online J, 19(11), https:\/\/doi.org\/10.5070\/D31911020392.","DOI":"10.5070\/D31911020392"},{"key":"3741_CR47","doi-asserted-by":"publisher","unstructured":"A. Treesirichod, S. Chaithirayanon, T. Chaikul, S. Chansakulporn, (Oct. 2021) The randomized trials of 10% urea cream and 0.025% tretinoin cream in the treatment of acanthosis nigricans, Journal of Dermatological Treatment, 32(7):837\u2013842, https:\/\/doi.org\/10.1080\/09546634.2019.1708855.","DOI":"10.1080\/09546634.2019.1708855"},{"key":"3741_CR48","doi-asserted-by":"publisher","unstructured":"M. Lod\u00e9n, P. Bostr\u00f6m, M. Kneczke Distribution and Keratolytic Effect of Salicylic Acid and Urea in Human Skin.Skin Pharmacol Physiol, 8(4):173\u20131781995 https:\/\/doi.org\/10.1159\/000211343.","DOI":"10.1159\/000211343"},{"key":"3741_CR49","doi-asserted-by":"publisher","unstructured":"L. Celleno, (Nov. 2018) Topical urea in skincare: A review, Dermatol Ther, 31(6):e12690, https:\/\/doi.org\/10.1111\/dth.12690.","DOI":"10.1111\/dth.12690"},{"key":"3741_CR50","doi-asserted-by":"publisher","unstructured":"E. J. Van Scott, (Oct. 1974) Control of keratinization with alpha-hydroxy acids and related compounds. I. Topical treatment of ichthyotic disorders, Arch Dermatol, 110(4):586\u2013590, https:\/\/doi.org\/10.1001\/archderm.110.4.586.","DOI":"10.1001\/archderm.110.4.586"},{"key":"3741_CR51","doi-asserted-by":"publisher","unstructured":"T. Arif (Aug. 2015) Salicylic acid as a peeling agent: a comprehensive review.Clin Cosmet Investig Dermatol, 455, https:\/\/doi.org\/10.2147\/CCID.S84765.","DOI":"10.2147\/CCID.S84765."},{"key":"3741_CR52","doi-asserted-by":"publisher","unstructured":"H.-W. Lee, S.-E. Chang, M.-W. Lee, J.-H. Choi, K.-C. Moon, J.-K. Koh, (Mar. 2005 ) Hyperkeratosis of the nipple associated with acanthosis nigricans: Treatment with topical calcipotriol, J Am Acad Dermatol, 52(3):529\u2013530, https:\/\/doi.org\/10.1016\/j.jaad.2004.09.028.","DOI":"10.1016\/j.jaad.2004.09.028"},{"key":"3741_CR53","doi-asserted-by":"publisher","unstructured":"S. Gregoriou, V. Anyfandakis, P. Kontoleon, E. Christofidou, D. Rigopoulos, G. Kontochristopoulos, (Jan. 2008) Acanthosis nigricans associated with primary hypogonadism: Successful treatment with topical calcipotriol, Journal of Dermatological Treatment, 19(6):373\u2013375, https:\/\/doi.org\/10.1080\/09546630802050506.","DOI":"10.1080\/09546630802050506"},{"key":"3741_CR54","doi-asserted-by":"publisher","unstructured":"B\u00d6hm, Luger, (Nov. 1998) Metze Treatment of mixed-type acanthosis nigricans with topical calcipotriol.British Journal of Dermatology, 139, 5,932\u2013934 https:\/\/doi.org\/10.1046\/j.1365-2133.1998.02538.x.","DOI":"10.1046\/j.1365-2133.1998.02538.x"},{"key":"3741_CR55","doi-asserted-by":"publisher","unstructured":"A. Zayed, R. M. Sobhi, D. M. Abdel Halim, (Jun. 2014) Using trichloroacetic acid in the treatment of acanthosis nigricans: a pilot study, Journal of Dermatological Treatment, 25(3):223\u2013225, https:\/\/doi.org\/10.3109\/09546634.2012.674194.","DOI":"10.3109\/09546634.2012.674194"},{"key":"3741_CR56","unstructured":"D. K. S. M. K. M. A. T. H. Rajegowda (2019) To compare the efficacy and safety of trichloroacetic acid peel with topical tretinoin in the treatment of acanthosis nigricans: A randomized controlled study. Journal of Pakistan Association of Dermatology, 29:170\u2013175"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03741-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-024-03741-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03741-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T15:04:01Z","timestamp":1736175841000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-024-03741-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,6]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3741"],"URL":"https:\/\/doi.org\/10.1007\/s00403-024-03741-3","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,6]]},"assertion":[{"value":"24 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"179"}}